The store will not work correctly when cookies are disabled.
Sodium 5-bromo-3-chlorobenzo[h]isoquinoline-8-carboxylate
ID: ALA4874370
PubChem CID: 137464090
Max Phase: Preclinical
Molecular Formula: C14H6BrClNNaO2
Molecular Weight: 336.57
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C([O-])c1ccc2c(c1)cc(Br)c1cc(Cl)ncc12.[Na+]
Standard InChI: InChI=1S/C14H7BrClNO2.Na/c15-12-4-8-3-7(14(18)19)1-2-9(8)11-6-17-13(16)5-10(11)12;/h1-6H,(H,18,19);/q;+1/p-1
Standard InChI Key: PSDIYGDATFEDLQ-UHFFFAOYSA-M
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
36.6374 -13.7024 0.0000 Na 0 0 0 0 0 15 0 0 0 0 0 0
30.8909 -11.1476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8897 -11.9713 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.6019 -12.3802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6001 -10.7346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3129 -11.1440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3136 -11.9671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7298 -11.1371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0166 -10.7296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7346 -11.9634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0230 -12.3705 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0229 -13.1890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7336 -13.6013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4458 -13.1850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4425 -12.3679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1592 -13.5951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1623 -14.4164 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.8695 -13.1797 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.0112 -9.9125 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
30.1827 -10.7398 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 7 2 0
6 5 2 0
5 2 1 0
6 7 1 0
7 11 1 0
10 8 1 0
8 9 2 0
9 6 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 10 2 0
14 16 1 0
16 17 2 0
16 18 1 0
9 19 1 0
2 20 1 0
M CHG 2 1 1 18 -1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 336.57 | Molecular Weight (Monoisotopic): 334.9349 | AlogP: 4.50 | #Rotatable Bonds: 1 |
Polar Surface Area: 50.19 | Molecular Species: ACID | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.64 | CX Basic pKa: ┄ | CX LogP: 3.99 | CX LogD: 0.66 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.53 | Np Likeness Score: -0.36 |
References
1. (2020) Anti-cancer/anti-fibrosis compounds, |